Side-by-side comparison of AI visibility scores, market position, and capabilities
Mental health provider marketplace matching patients with therapists and psychiatrists accepting insurance; San Francisco-based;
Path Mental Health is a San Francisco-based mental health platform that matches patients with therapists, psychologists, and psychiatrists who accept insurance, addressing the core access barrier in mental healthcare. Path handles the insurance verification, paperwork, and administrative overhead of connecting patients to in-network mental health providers, offering both individual therapy and medication management services. The platform targets the large population of individuals who want to use their health insurance for mental health care but struggle to find providers who are accepting new patients and take their specific insurance plan. Path works with major commercial insurers and provides access to licensed providers via telehealth and in-person sessions depending on location. Founded in 2019, Path raised over $120M from investors including Andreessen Horowitz and Foresite Capital. The company competes with Alma, Headway, and Grow Therapy in the therapist network and patient matching market.
Amgen (AMGN) reported $33.4B revenue in FY2024, up 19% YoY (post-Horizon acquisition). Top-5 global biotech. 10+ blockbuster drugs. ~24,000 employees. HQ: Thousand Oaks, CA. Market cap ~$130B.
Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologics and brought landmark medicines including Epogen, Neupogen, and Enbrel to market. The company reported revenues of $33.4B in FY2024, up 19% year-over-year, boosted by the transformational $28B acquisition of Horizon Therapeutics in October 2023.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.